Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Frontiers in Pharmacology|July 15, 2021
Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous LeukemiaMeike Kaehler, Ingolf Cascorbi
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Germline variants in cancer therapyMeike Kaehler, Ingolf Cascorbi
Handbook of Experimental Pharmacology|March 7, 2023
Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid LeukemiaMeike Kaehler, Ingolf Cascorbi
Molecular Pharmaceutics|March 17, 2021
Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux TransportersCharles Awortwe, Henrike Bruckmueller, Meike Kaehler, et al.
Frontiers in Pharmacology|October 2, 2025
The role of the lysine histone methylase KMT2D in chronic myeloid leukemiaLina Schlemminger, Inga Nagel, Inga Vater, et al.
Frontiers in Pharmacology|August 6, 2024
Molecular biomarkers of leukemia: convergence-based drug resistance mechanisms in chronic myeloid leukemia and myeloproliferative neoplasmsMeike Kaehler, Nikolas von Bubnoff, Ingolf Cascorbi, et al.
Oncology Letters|July 18, 2024
BTK acts as a modulator of the response to imatinib in chronic myeloid leukemiaLena Schmidlechner, Inga Nagel, Inga Vater, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 10, 2017
MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2Charles Awortwe, Meike Kaehler, Bernd Rosenkranz, et al.
Anticancer Research|September 30, 2024
Enhancing Retinoic Acid-mediated Effects Through Inhibition of CYP26A1, CYP26B1 and HGF Signaling in Neuroblastoma CellsReema Sami Issa, Meike Kaehler, Nina Sophie Pommert, et al.
Pharmacogenomics|February 20, 2016
Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistanceOliver Bruhn, Katharina Drerup, Meike Kaehler, et al.
Pageof 17